ENST00000513471.5:n.926G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000513471.5(C1QTNF3):​n.926G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.393 in 165,080 control chromosomes in the GnomAD database, including 13,265 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 11966 hom., cov: 32)
Exomes 𝑓: 0.43 ( 1299 hom. )

Consequence

C1QTNF3
ENST00000513471.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.232

Publications

13 publications found
Variant links:
Genes affected
C1QTNF3 (HGNC:14326): (C1q and TNF related 3) Enables identical protein binding activity. Involved in several processes, including cellular triglyceride homeostasis; negative regulation of NIK/NF-kappaB signaling; and regulation of cytokine production. Acts upstream of or within negative regulation of gluconeogenesis. Located in extracellular exosome and membrane. [provided by Alliance of Genome Resources, Apr 2022]
C1QTNF3-AMACR (HGNC:49198): (C1QTNF3-AMACR readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring C1q and tumor necrosis factor related protein 3 (C1QTNF3) and alpha-methylacyl-CoA racemase (AMACR) genes on chromosome 5. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is thus not likely to produce a protein product. [provided by RefSeq, Mar 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.629 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C1QTNF3NM_181435.6 linkc.*411G>A 3_prime_UTR_variant Exon 6 of 6 ENST00000382065.8 NP_852100.3
C1QTNF3NR_146599.1 linkn.1962G>A non_coding_transcript_exon_variant Exon 12 of 12
C1QTNF3NM_030945.4 linkc.*411G>A 3_prime_UTR_variant Exon 6 of 6 NP_112207.1
C1QTNF3-AMACRNR_037951.1 linkn.764+415G>A intron_variant Intron 6 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C1QTNF3ENST00000382065.8 linkc.*411G>A 3_prime_UTR_variant Exon 6 of 6 1 NM_181435.6 ENSP00000371497.3
C1QTNF3-AMACRENST00000382079.3 linkn.689+415G>A intron_variant Intron 6 of 8 2 ENSP00000371511.3

Frequencies

GnomAD3 genomes
AF:
0.390
AC:
59299
AN:
151904
Hom.:
11940
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.396
Gnomad AMI
AF:
0.391
Gnomad AMR
AF:
0.449
Gnomad ASJ
AF:
0.354
Gnomad EAS
AF:
0.486
Gnomad SAS
AF:
0.648
Gnomad FIN
AF:
0.317
Gnomad MID
AF:
0.475
Gnomad NFE
AF:
0.360
Gnomad OTH
AF:
0.415
GnomAD4 exome
AF:
0.428
AC:
5585
AN:
13058
Hom.:
1299
Cov.:
0
AF XY:
0.443
AC XY:
3068
AN XY:
6926
show subpopulations
African (AFR)
AF:
0.410
AC:
91
AN:
222
American (AMR)
AF:
0.472
AC:
1146
AN:
2428
Ashkenazi Jewish (ASJ)
AF:
0.398
AC:
101
AN:
254
East Asian (EAS)
AF:
0.486
AC:
323
AN:
664
South Asian (SAS)
AF:
0.640
AC:
1193
AN:
1864
European-Finnish (FIN)
AF:
0.310
AC:
62
AN:
200
Middle Eastern (MID)
AF:
0.346
AC:
9
AN:
26
European-Non Finnish (NFE)
AF:
0.355
AC:
2452
AN:
6908
Other (OTH)
AF:
0.423
AC:
208
AN:
492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
140
279
419
558
698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.391
AC:
59369
AN:
152022
Hom.:
11966
Cov.:
32
AF XY:
0.394
AC XY:
29294
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.396
AC:
16433
AN:
41466
American (AMR)
AF:
0.450
AC:
6880
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.354
AC:
1228
AN:
3468
East Asian (EAS)
AF:
0.486
AC:
2510
AN:
5166
South Asian (SAS)
AF:
0.648
AC:
3124
AN:
4818
European-Finnish (FIN)
AF:
0.317
AC:
3342
AN:
10530
Middle Eastern (MID)
AF:
0.483
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
0.360
AC:
24467
AN:
67974
Other (OTH)
AF:
0.421
AC:
889
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1875
3750
5626
7501
9376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
578
1156
1734
2312
2890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.376
Hom.:
29948
Bravo
AF:
0.397
Asia WGS
AF:
0.588
AC:
2044
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.2
DANN
Benign
0.51
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs840386; hg19: chr5-34020277; API